CLASS I Device recall · Reported 15 Aug 2018 · FDA Enforcement Report

AmniSure ROM Test under the following labels recalled by Qiagen Sciences

Qiagen Sciences is recalling AmniSure ROM Test under the following labels, distributed nationwide in the US. The recall was initiated on 18 May 2018 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codes1) UDI 14053228022319; Lot Numbers - 557016546, 557016547 & 5600115, Exp Date 7/28/2020 2) UDI 14053228022333; Lot Number - 557016409, Exp Date 7/28/2020
Quantity recalled1620 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2577-2018
FDA event ID
80404
Recalling firm
Qiagen Sciences, Germantown, MD
Classification
Class I
Status
Terminated
Recall initiated
18 May 2018
FDA classified
8 Aug 2018
Reported
15 Aug 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

18 May 2018Recall initiated by company
8 Aug 2018Classified by FDA+82 days
15 Aug 2018Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Potential for control line not appearing on the test strip

Product as listed by the FDA

AmniSure ROM Test under the following labels: 1) Catalog Number FMRT-1-25 and 2) Catalog Number FMRT-1-25-CA Product Usage: Rapid, non-instrumented, qualitative immunochromatographic test for the in vitro detection of amniotic fluid in vaginal discharge of pregnant women.

Where it was distributed

Worldwide - US Nationwide distribution an in the country of , Canada

Nationwide

Questions about this recall

Why was it recalled?

Potential for control line not appearing on the test strip

Which lots are affected?

1) UDI 14053228022319; Lot Numbers - 557016546, 557016547 & 5600115, Exp Date 7/28/2020 2) UDI 14053228022333; Lot Number - 557016409, Exp Date 7/28/2020

Where was it sold?

Worldwide - US Nationwide distribution an in the country of , Canada

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Qiagen Sciences

All 23

Other Test Kits & Diagnostics recalls

All 2,675
ReportedClassRecallCompanyReasonWhere
DeviceCLASS IINextseq 550Dx Instrument recalled by IlluminaIlluminaOtherNationwide
DeviceCLASS IINovaSeq 6000Dx Instrument recalled by IlluminaIlluminaOtherNationwide
DeviceCLASS IILiaison Plex Gram-Negative Blood Culture Assay recalled by LuminexLuminexPotency & AssayNationwide
DeviceCLASS IIMiSeq Dx Instrument recalled by IlluminaIlluminaOtherNationwide
DeviceCLASS IITechno-Path Multichem AE Unassayed Level recalledTechno-path ManufacturingPotency & AssayNationwide